Welcome to Nofinity

A major regulatory shift has just transformed the future of peptide therapy and longevity medicine in the US. On July 23-24, 2026, the FDA's independent Pharmacy Compounding Advisory Committee (PCAC) voted to recommend six out of seven evaluated peptides for compounding – overruling the agency's own staff recommendations.

• In 2023, the FDA placed 19 popular peptides (including BPC-157, TB-500) into Category 2 – effectively banning them from regulated compounding pharmacies.
• Consequence: Patients turned to unregulated online vendors (black market), creating safety risks.
• April 2026: Following policy shifts at the Department of Health and Human Services, a public hearing was scheduled.

1. Clinical Reality: Physicians presented extensive real-world evidence of therapeutic success in chronic inflammatory bowel conditions, severe musculoskeletal injuries, and age-related tissue degeneration where standard treatments failed.
2. Public Health Hazard: An outright ban drives patients to unregulated markets lacking any quality controls (sterility, dosing, purity). The panel recognized regulated pharmacies as a safety buffer.
3. Biocompatibility: Synthetic peptides mimic endogenous molecules; existing pharmacopeial standards can adequately manage concerns about endotoxins, purity, and sequence fidelity.

• The advisory vote is non-binding – but the FDA historically follows panel recommendations in most cases.
• Permanent inclusion in the official "Positive List" requires formal rulemaking (8–12 months).
• Interim solution: Medical associations and pharmacy alliances are petitioning for immediate reclassification to Category 1 (enforcement discretion). This would allow compounding pharmacies to resume production right away.

This development signals a return to transparent, physician-supervised access to promising regenerative molecules. Key priorities moving forward:

• rigorous quality assurance (pharmaceutical-grade purity)
• GMP-compliant manufacturing
• encouragement of formal clinical trials to validate long-term efficacy

The Bitcoin price has surged from $68,000 to $87,000 in just two weeks, approaching the predicted October target of $90,000. Exchange-traded funds (ETFs) are seeing strong inflows, and long-term holders have significantly reduced their selling, which is considered a bullish signal. The price has broken through the 50-week moving average, suggesting further gains, while institutional investors are increasingly using MicroStrategy to gain exposure to Bitcoin. The purchasing power of the US dollar continues to decline due to inflation.

If building your own trading bot feels overwhelming, there are professional developers who have done it for free on GitHub. This video covers my top three repositories for executing trades, along with setup and usage tips.

• Function: Free, open-source crypto trading bot in Python, supporting all major exchanges and controlled via web UI or Telegram.
• Features: Backtesting, plotting, money management, and machine learning for strategy optimization.
• Key Point: Beginner-friendly with pre-built parameters and risk settings. Also supports stocks, commodities, and FX via exchanges like Binance or Hyperliquid.
• Live Trading: Control via Telegram commands (e.g., /performance, /start, /stop). Includes built-in backtesting with historical data and a dry run feature.
• Conclusion: Perfect for those wanting a ready-to-use solution without deep programming.

• Function: Personal trading agent with self-improving features to generate and test strategies.
• Features: Answer market questions, backtest, review trades, read institutional filings, run analyst teams, and access a library of over 450 pre-built alpha factors.
• Application: Ideal as a research and strategy development tool before live trading. Can connect to Alpaca for paper trading.
• Example: Tested momentum strategies for NVDA, META, AAPL, MSFT, and AMZN, backtested with realistic fees, and set up paper trading with $100k.

• Function: AI trading terminal for stocks, commodities, forex, and crypto.
• Features: Autopilot mode, no need for personal hardware – everything runs on their servers. Provides a dashboard with liquidation maps, order books, signal matrix, and orchestration.
• Application: Create and execute strategies directly via the web interface on Hyperliquid or other exchanges.
• Advantage: Very user-friendly as the infrastructure is pre-built.

• Recommendation: Try all three repos as they serve different purposes. You can combine tools, e.g., use Vibe Trading for strategy development and Freak Trade for execution.
• Tip: Experiment with paper trading to test strategies risk-free. This is the best way to learn and improve AI trading.
• Additional Info: For setup guides and community access, check the description.

This video critically examines the current AI euphoria, questioning whether we are in a bubble and whether it's time to take short positions – especially on NVIDIA.

📈 The Spending Pyramid

• We only see the tip of the financial pyramid: high profits, strong growth – everything looks great.
• But the lower layer (future commitments 5x current spending) hasn't yet hit the books.
• NVIDIA forecasts 70% growth – correct as long as companies stick to their commitments.
• Planned spending is in the trillions per year – boosting profits now, but depreciation is coming.

💸 Depreciation as a Game-Changer

• When investments (e.g., $3 trillion over 3 years) hit balance sheets, annual depreciation could be ~$500 billion (assuming 6-year useful life).
• Hyperscalers would need to triple their current profits just to cover depreciation and then make some money.
• Top 10 S&P 500: $600B net income – minus $500B depreciation = $100B – negligible vs. market cap.
• By 2029, $1 trillion in additional operating profits needed to justify the spend – that's the market's implicit expectation.

⚠️ Dot-Com Comparison

• The author draws parallels to the dot-com bubble: High capex leads to overcapacity, price wars, and eventual collapse.
• He cites Michael Burry („The Big Short“): Stock market booms peak midway through the capex cycle.
• China could undercut profits (Elon Musk sees China as potential AI world leader).
• AI is getting cheaper (e.g., video streaming costs dropped dramatically) – bad for high ROI expectations.

🛠️ Action: Short or Puts?

• The author avoids long positions (too risky).
• He considers put options on NVIDIA as a hedge or speculation.
• Example: A put with strike $100 (current ~$200) costs ~$1 – if NVIDIA falls to $50, 40x return. Cheap „disaster hedge“.
• However, an 80% decline in 12 months is unlikely – most options expire worthless.
• Michael Burry also uses puts but constantly adjusts.

🔮 Outlook

• The author expects a possible tipping point around 2027 when depreciation fully hits.
• For now: „Don't short too early, but hedge defensively.“
• Recommendation: 1–2% of portfolio in cheap out-of-the-money puts as catastrophe insurance.
• Midterms 2024/25 bring additional volatility.

Conclusion: The AI bubble may burst, but timing is uncertain. A small hedge with OTM puts is an interesting low-risk strategy to profit from a potential crash.

The creator greets the audience and immediately addresses his main point: his failed prediction. He admits he was wrong when he doubted that Bitcoin could surpass the May high. He emphasizes that he is not making excuses or trying to sugarcoat the situation, but rather openly acknowledges the misjudgment.

• Confirmation of Error: The creator confirms that Bitcoin has indeed exceeded the May high.
• Price Action: He mentions that the price is above the 50-week average and has risen to nearly $86,000 (85,815 USD).
• Personal Reflection: He explains that it is difficult to admit mistakes, but it is an inherent part of financial markets. Over time, he has grown accustomed to being both loved and hated.

• Missed Opportunity: The creator regrets that his planned buying strategy for July (with risk under 0.3) only lasted five days. He takes this as a lesson to capitalize more on opportunities when they arise.
• Humility and Growth: He reflects that this experience helps him stay humble, while also slightly preferring to stay out of the spotlight.

• Acknowledging Others: He praises other analysts who were right and recommends his audience follow them, as their insights are currently more valuable.
• Price Outlook: The creator remains open-minded about where Bitcoin might go for the rest of the year.

He thanks his viewers for their patience, as he has not been able to upload videos for the past two weeks. He was in New Zealand, a lifelong dream destination. He is glad to be back and ends the video with gratitude and a friendly farewell.

Dr. Chris Thompson explains the functions of each segment:

• Esophagus: Transports food to the stomach; problems like achalasia or reflux can cause swallowing difficulties.
• Stomach: Stretches to accommodate meals, mechanically breaks down food, produces ghrelin (hunger hormone).
• Small intestine: Absorbs nutrients; its wall is only one cell thick, with tight junctions and a mucus layer as barriers.
• Large intestine: Home of the microbiome; produces butyrate, critical for gut health and satiety signals.

„Feed your microbes, or they will eat you.“

• Fiber is the main food for the microbiome. Without enough fiber, microbes start eating the protective mucus layer, produce less butyrate, and tight junctions weaken.
• Recommended daily fiber intake: 35 g for men, 25 g for women. Resistant starch (e.g., raw potato starch) improves fatty liver and insulin sensitivity.
• Fermented foods (kimchi, sauerkraut, kefir, kombucha) increase microbiome diversity and lower inflammatory markers.

• Rule of thumb: No more than 3× per day, no fewer than 1× every 3 days. Hard, small pellets (scybala) indicate fiber deficiency.
• Dark, tarry stool may signal bleeding in the upper GI tract.
• Regular colon cancer screening recommended starting at age 45 (colonoscopy every 10 years or stool tests).

Metabolic dysregulation follows a predictable pattern:

1. Caloric excess → glucose spikes (detectable with a CGM)
2. Elevated fasting insulin (simple blood test)
3. Ectopic fat (fatty liver, visceral fat) → measured via waist circumference, ALT, DEXA scan
4. Insulin resistance (HOMA-IR > 2)
5. Metabolic inflexibility (body cannot switch between fat and carb burning)

→ Early detection is key before diabetes or organ damage occurs.

• GLP-1 agonists (Ozempic, Mounjaro) are highly effective but cause superphysiological levels. Side effects: nausea, muscle loss (especially without resistance training).
• Microdosing (personalized dose adjustment) can reduce side effects and maintain weight loss.
• Endoscopic procedures (ESG – gastric sleeve, magnetic anastomosis to bypass small intestine) target individual hormones like ghrelin or GLP-1 without massive overdosing.
• Combining procedures with low-dose drugs may be the future.

• AI-assisted surgery: Real-time coaching, vessel detection, stitch optimization.
• Gene therapy: Single injection of a viral vector into the pancreas that produces GLP-1 in a nutrient-responsive manner – similar to natural insulin release. Currently in clinical trials.

• Resistance training is essential to prevent muscle loss during weight loss.
• Zone 2 cardio improves fat burning; HIIT mobilizes visceral fat.
• Focus on olive oil, moderate butter, and fatty fish at least 2× per week (or algae omega‑3). Artificial sweeteners are better than high-fructose corn syrup but can be problematic in processed foods.
• Time-restricted eating (intermittent fasting) supports insulin regulation; short-term microbiome stress is outweighed by long-term benefits.

„You must feed your microbes, or they will eat you.“ – Dr. Chris Thompson

The combination of fiber, fermented foods, exercise, early diagnostics, and – if needed – targeted endoscopic or drug treatments offers the best path to sustainable gut health and weight management.

In this Bankless episode, David talks with Johan about recent developments at Robinhood Chain and their impact on the crypto world.

SEC Exemption for Tokenization

• The SEC issued an innovation exemption for tokenized stocks after the "CLARITY Act" failed to advance.
• This exemption allows Robinhood to offer products like tokenized stocks in the U.S., which was previously not possible.
• Johan emphasizes this is the next big step for tokenization, although it's a five-year exemption with many open questions.

Differences and Adaptations

• Robinhood's existing tokenized stocks are debt instruments, not direct equity representations. The new rule targets true tokenized securities with KYC and permissioning.
• Robinhood plans to adapt to new regulations, though no concrete plans have been publicly disclosed yet.

Challenges and Solutions

• Trading tokenized stocks operates 24/7, leading to price dislocations on weekends. Robinhood uses market-making pools to address these discrepancies.
• Example: After a 3-day weekend, liquidity was increased to avoid price distortions.

Future Outlook and Ecosystem

• Robinhood plans to tokenize more assets like commodities and possibly its own stock.
• The team is working on an improved user interface and integrations to attract more users.
• Ethereum remains central to Robinhood Chain, leveraging security and decentralization from Ethereum's network.

Other Topics

• Johan discusses the partnership with Offchain Labs (OCL) and the importance of in-house development where it makes a difference.
• Open questions remain on taxation and regulation of DeFi activities, which Robinhood seeks to answer.
• Future developments may include AI agent-driven automated strategies exploiting arbitrage opportunities.

Overall, Robinhood is optimistic and committed to advancing tokenization while navigating regulatory hurdles.